Biological Specialty is categorized under Blood Plasma in Colmar, PA and active since 1979.
Biological Specialty was established in 1979, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Blood Plasma business, which does work in the BOTH market, and is classified as a Blood Plasma, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Aileen Widdoss, Vice President at the company’s single location by writing to 2165 North Line St, Colmar, Pennsylvania PA 18915 or by phoning (215) 997-8771. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Biological Specialty |
| Contact Person: | Aileen Widdoss, Vice President |
| Address: | 2165 North Line St, Colmar, Pennsylvania 18915 |
| Phone Number: | (215) 997-8771 |
| Website Address: | biospecialty.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 1979 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Blood Plasma |
| SIC Code: | 5122 |
| NAICS Code: | 6211110 |
| Share This Business: |
Biological Specialty was started in 1979 to provide professional Blood Plasma under the SIC code 5122 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Aileen Widdoss, Vice President for inquiries that concern Biological Specialty by calling the company number (215) 997-8771, as your correspondence is most welcome. Additionally, the physical location of the single location of Biological Specialty can be found at the coordinates 40.26421,-75.25375 as well as the street address 2165 North Line St in Colmar, Pennsylvania 18915.
For its online presence, you may visit Biological Specialty’s website at biospecialty.com and engage with its social media outlets through on Twitter and on Facebook.